MedTrace Logo

Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes

NCT03134417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2021-09-27

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of a combined vitamin D and magnesium supplementation on parathyroid hormone and cardiometabolic health in persons living with obesity.

Conditions

  • Overweight and Obesity
  • Vitamin D Deficiency
  • Magnesium Deficiency
  • Cardiovascular Risk Factor

Interventions

DIETARY_SUPPLEMENT

Vitamin D and magnesium

Daily vitamin D and magnesium supplements are given to participants daily for 12 weeks.

DIETARY_SUPPLEMENT

Vitamin D

Daily vitamin D supplements are given to participants daily for 12 weeks.

DIETARY_SUPPLEMENT

Placebo

Daily placebo are given to participants daily for 12 weeks.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2020-12-31
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03134417 on ClinicalTrials.gov